216 related articles for article (PubMed ID: 31935741)
1. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
[TBL] [Abstract][Full Text] [Related]
2. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
Hanlon EC
Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
[TBL] [Abstract][Full Text] [Related]
3. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
Pai AY; Wenziger C; Streja E; Argueta DA; DiPatrizio NV; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D; Moradi H
Am J Nephrol; 2021; 52(1):59-68. PubMed ID: 33601382
[TBL] [Abstract][Full Text] [Related]
4. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
Thompson Z; Argueta D; Garland T; DiPatrizio N
Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
[TBL] [Abstract][Full Text] [Related]
6. Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease.
Moradi H; Park C; Igarashi M; Streja E; Argueta DA; Soohoo M; Daglian J; You AS; Rhee CM; Kashyap ML; DiPatrizio NV; Vaziri ND; Kalantar-Zadeh K; Piomelli D
J Endocr Soc; 2019 Oct; 3(10):1869-1880. PubMed ID: 31583368
[TBL] [Abstract][Full Text] [Related]
7. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers.
Artegoitia VM; Foote AP; Lewis RM; King DA; Shackelford SD; Wheeler TL; Freetly HC
J Anim Sci; 2016 Dec; 94(12):5177-5181. PubMed ID: 28046144
[TBL] [Abstract][Full Text] [Related]
9. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
[TBL] [Abstract][Full Text] [Related]
10. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.
Brocato B; Zoerner AA; Janjetovic Z; Skobowiat C; Gupta S; Moore BM; Slominski A; Zhang J; Schenone M; Phinehas R; Ferry RJ; Dick E; Hubbard GB; Mari G; Schlabritz-Loutsevitch N
Placenta; 2013 Nov; 34(11):983-9. PubMed ID: 24008071
[TBL] [Abstract][Full Text] [Related]
12. BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels.
Grasso S; Santonico M; Pennazza G; Zompanti A; Piccoli A; Bisogno T; Maccarrone M
Sensors (Basel); 2021 Jan; 21(2):. PubMed ID: 33445599
[TBL] [Abstract][Full Text] [Related]
13. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
[TBL] [Abstract][Full Text] [Related]
14. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
[TBL] [Abstract][Full Text] [Related]
15. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
[TBL] [Abstract][Full Text] [Related]
16. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.
Castonguay-Paradis S; Lacroix S; Rochefort G; Parent L; Perron J; Martin C; Lamarche B; Raymond F; Flamand N; Di Marzo V; Veilleux A
Sci Rep; 2020 Sep; 10(1):15975. PubMed ID: 32994521
[TBL] [Abstract][Full Text] [Related]
17. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
[TBL] [Abstract][Full Text] [Related]
19. Circulating endocannabinoids and affect regulation in human subjects.
Coccaro EF; Hill MN; Robinson L; Lee RJ
Psychoneuroendocrinology; 2018 Jun; 92():66-71. PubMed ID: 29627714
[TBL] [Abstract][Full Text] [Related]
20. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.
Yi B; Nichiporuk I; Nicolas M; Schneider S; Feuerecker M; Vassilieva G; Thieme D; Schelling G; Choukèr A
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():92-7. PubMed ID: 26780604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
